(11) 98705-3426
TrademarkIQ íconeTrademarkIQ
Voltar para busca
Dado oficial do USPTO

I

Sabia que essa marca já está registrada no Estados Unidos?

Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.

Active USPTO registrationTipo: MistaEscritório: US

Snapshot rápido

I

ST13

US500000079275839

Classe

5, 42, 44

Pedido

79275839

Registro

6279502

Diagnóstico de risco e oportunidade

Leitura executiva para decisão de naming, protocolo e monitoramento.

Atenção: há risco ativo

Situação USPTO

Active USPTO registration

Tipo de processo

Pedido e registro

Eventos registrados

36

Atualização mais recente

03/03/2026

Classificação

Registrada

Tipo de marca

Mista

Classes Nice

5, 42, 44

Data de depósito

25/07/2019

Data de registro

02/03/2021

Data de expiração

-

Ação recomendada

Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.

Próximo passo

Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.

Dados completos do processo

Campos estruturados da autoridade responsável e do histórico oficial.

Data da situação

02/03/2021

Última transação

03/03/2026

Escritório responsável

United States Patent and Trademark Office

Código da situação

700

Cadastro oficial

Principal Register

Código do desenho

3

Tipo de titular

03

Localização do titular

JP

Examinador

AGREDA, SAMANTHA LEIGH

Unidade examinadora

N50

Localização atual

PUBLICATION AND ISSUE SECTION

Descrição da marca

The mark consists of six shapes; The top two shapes colored in lime green resemble a lowercase letter "I"; Each of the remaining four shapes colored in forest green are comprised of one or more right ascending diagonal strokes with rounded edges of varying length; Two of the shapes colored in forest green are comprised of multiple right ascending diagonal strokes, what are connected by left ascending diagonal strokes of varying width with concave sides.

Titulares e representantes

Titulares

bitBiome, Inc.

Representantes

Stacey J. Watson Markery Law LLC

Classificação técnica

Classes Nice

Classe 5Classe 42Classe 44

Códigos Vienna

Sem códigos Vienna disponíveis.

Produtos e serviços

Classe 5

Pharmaceutical preparations for the treatment of allergiesalzheimer diseaseadrenocortical insufficiencyallotype pneumoniaalveobronchiolitisangiocholitisarthritisasthmatoid bronchitisasthmaattention deficit hyperactivity disorderautismauto-immune diseases and disordersautoinflammatory diseasebacteremiabacterial infectionbacterial pneumoniabacterial septicemiabacteroides fragilisbacteroides thetaiotaomicronbacteroides uniformisbacteroides vulgatusbeta thalassemia and myelodysplastic syndromesbiliary tract cancerpneumoniablood diseaseblood disordersbone growth disordersbone and joint infectionsbreast cancerbronchitisbronchiectasiscancercardiovascular diseasescentral nervous system diseases and disorderscervical cancercholecystitischronic congestive heart failureclostridium perfringenscollagen diseasescolorectal cancercommunity-acquired pneumoniacongestive heart failureconstipationcrohn's diseasecystitisdeep suppurative diseasedementiadepressiondiabetesdermatologic diseasesduodenal ulcerdysenteryedematous statesendocarditisendocrine diseases and disordersendometrial cancerendometriosisendonephritisenteritisenterococcus faecalisepididymitisepilepsyesophageal cancerdysenteryfebrile neutropenic infectionsgastrointestinal diseases and disordersgastric cancergastric ulcergenetic diseases and disordersgonorrheagraft-versus-host diseasegranulocytopeniagynecological infectionshead and neck cancerheart diseasehematologic disordershepatic cirrhosishypertensionhyperlipidemihypercholesterolemiahypognathadenitisincontinenceinflammation and inflammatory diseasesinflammatory bowel diseaseintra-abdominal infectionsintrauterine infectionirritable bowel syndromekidney diseases and disordersleukemialiver disorders and diseaseslower respiratory tract infectionslung cancerlymphomamelanomameningitismenopausalmetabolic diseases and disordersmultiple myelomamultiple sclerosismuscular dystrophymusculoskeletal diseases and disordersmyeloproliferative diseasesmyelofibrosisnasosinusitisneoplastic diseasesneurodegenerative diseases and disordersneurological diseases and disordersneuromuscular and non-gonococcal urethritisnosocomial pneumoniaobesityobsessive-compulsive disorderoncological diseases and disordersophthalmic diseasesosteoarthritisotitis mediaovarian cancerpainpancreatic cancerparkinson's diseasepeptostreptococcus microsperitonitis and septicemiapneumoniapolymicrobic infectionsprevention of chest painprostate cancerprostatitispseudomonas aeruginosapyelocystitipyelonephritisreflux sophagitisrenal dysfunctionrheumatic disordersrespiratory diseasesrespiratory tract infectionsschizophreniasclerodermaseizuressepticemiasexual disfunctionsickle cell diseaseskin disorders and diseasesskin and skin structure infectionssolid organ transplant rejectionspasmsstaphylococcus aureusstreptococcus anginosusstreptococcus intermadiusstreptococcus constellatusstrokesuperficial pyogenic infectionsuppurative lung diseasesyphilistransmissible alimentary toxicosisthe prevention of organ rejection by renal transplant patientstumorsulcerative colitisurethritisurinary tract infectionsurogenital tract infectionurothelial cancervaso-occulisive crisisviral diseases and disorderszollinger-ellison syndrome; pharmaceutical biological preparations for medical purposes for the treatment of allergiesalzheimer diseaseadrenocortical insufficiencyallotype pneumoniaalveobronchiolitisangiocholitisarthritisasthmatoid bronchitisasthmaattention deficit hyperactivity disorderautismauto-immune diseases and disordersautoinflammatory diseasebacteremiabacterial infectionbacterial pneumoniabacterial septicemiabacteroides fragilisbacteroides thetaiotaomicronbacteroides uniformisbacteroides vulgatusbeta thalassemia and myelodysplastic syndromesbiliary tract cancerpneumoniablood diseaseblood disordersbone growth disordersbone and joint infectionsbreast cancerbronchitisbronchiectasiscancercardiovascular diseasescentral nervous system diseases and disorderscervical cancercholecystitischronic congestive heart failureclostridium perfringenscollagen diseasescolorectal cancercommunity-acquired pneumoniacongestive heart failureconstipationcrohn's diseasecystitisdeep suppurative diseasedementiadepressiondiabetesdermatologic diseasesduodenal ulcerdysenteryedematous statesendocarditisendocrine diseases and disordersendometrial cancerendometriosisendonephritisenteritisenterococcus faecalisepididymitisepilepsyesophageal cancerdysenteryfebrile neutropenic infectionsgastrointestinal diseases and disordersgastric cancergastric ulcergenetic diseases and disordersgonorrheagraft-versus-host diseasegranulocytopeniagynecological infectionshead and neck cancerheart diseasehematologic disordershepatic cirrhosishypertensionhyperlipidemihypercholesterolemiahypognathadenitisincontinenceinflammation and inflammatory diseasesinflammatory bowel diseaseintra-abdominal infectionsintrauterine infectionirritable bowel syndromekidney diseases and disordersleukemialiver disorders and diseaseslower respiratory tract infectionslung cancerlymphomamelanomameningitismenopausalmetabolic diseases and disordersmultiple myelomamultiple sclerosismuscular dystrophymusculoskeletal diseases and disordersmyeloproliferative diseasesmyelofibrosisnasosinusitisneoplastic diseasesneurodegenerative diseases and disordersneurological diseases and disordersneuromuscular and non-gonococcal urethritisnosocomial pneumoniaobesityobsessive-compulsive disorderoncological diseases and disordersophthalmic diseasesosteoarthritisotitis mediaovarian cancerpainpancreatic cancerparkinson's diseasepeptostreptococcus microsperitonitis and septicemiapneumoniapolymicrobic infectionsprevention of chest painprostate cancerprostatitispseudomonas aeruginosapyelocystitipyelonephritisreflux sophagitisrenal dysfunctionrheumatic disordersrespiratory diseasesrespiratory tract infectionsschizophreniasclerodermaseizuressepticemiasexual disfunctionsickle cell diseaseskin disorders and diseasesskin and skin structure infectionssolid organ transplant rejectionspasmsstaphylococcus aureusstreptococcus anginosusstreptococcus intermadiusstreptococcus constellatusstrokesuperficial pyogenic infectionsuppurative lung diseasesyphilistransmissible alimentary toxicosisthe prevention of organ rejection by renal transplant patientstumorsulcerative colitisurethritisurinary tract infectionsurogenital tract infectionurothelial cancervaso-occulisive crisisviral diseases and disorderszollinger-ellison syndrome; pharmaceutical preparations for human useanalgesicsantibioticsanti-fungalsanti-infective preparationsanti-viralsanti-parasiticscytokine inhibitory drugs; human growth hormonesimmunosuppressantsimmunotherapies for the treatment of cancermedicated dermatological preparationspharmaceutical antibodies for disease testingdiagnosistreatment purposespharmaceutical preparations that modulate the immune systempharmaceutical and biological preparations for immunotherapyincluding T Cell therapysedativessmoking cessation preparationstranquillizersvaccines for human usevitamins; and preparations for destroying verminfungicidesherbicides

Classe 42

Structural and functional analysis of genomes; research and development in the field of microorganisms and cells for the healthcarescientificbiochemicalpharmaceuticalmedicalagriculturalfoodcosmeticanimal healthdiagnosticchemicalbioremediationsanitationoral careoil industries; pharmaceutical research and development; pharmaceutical product evaluation services; medical research; medical laboratory services; genetic testing for scientific research purposes

Classe 44

Medical screening; providing information relating to medical services; genetic testing for medical purposes

Publicações

Histórico de despachos e eventos da marca no USPTO.

36 publicações encontradas

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

02/03/2026

NREP

NEW REPRESENTATIVE AT IB RECEIVED

19/01/2024

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

20/06/2021

FICS

FINAL DISPOSITION NOTICE SENT TO IB

02/06/2021

FIMP

FINAL DISPOSITION PROCESSED

02/06/2021

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/06/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

02/03/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

15/12/2020

PUBO

PUBLISHED FOR OPPOSITION

15/12/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

25/11/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

12/11/2020

XAEC

EXAMINER'S AMENDMENT ENTERED

12/11/2020

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

12/11/2020

GNEA

EXAMINERS AMENDMENT E-MAILED

12/11/2020

CNEA

EXAMINERS AMENDMENT -WRITTEN

12/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

31/08/2020

GNRT

NON-FINAL ACTION E-MAILED

31/08/2020

CNRT

NON-FINAL ACTION WRITTEN

31/08/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

05/08/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/08/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/08/2020

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

10/07/2020

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

10/07/2020

ECDR

TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS

10/07/2020

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

10/07/2020

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

10/07/2020

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

10/07/2020

RFNT

REFUSAL PROCESSED BY IB

28/02/2020

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/02/2020

RFRR

REFUSAL PROCESSED BY MPU

10/02/2020

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

17/01/2020

CNRT

NON-FINAL ACTION WRITTEN

16/01/2020

MAFR

APPLICATION FILING RECEIPT MAILED

14/01/2020

DOCK

ASSIGNED TO EXAMINER

09/01/2020

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

09/01/2020

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

02/01/2020

Proteção contínua da sua marca

Seja avisado a cada novo depósito que ameace I ou a sua marca.

Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.